Mark Dickson, MD, Oncology, New York, NY, Memorial Sloan-Kettering Cancer Center

MarkADicksonMD

Oncology New York, NY

Hematologic Oncology

Instructor, Medicine, Weill Cornell Medical College

Dr. Dickson is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dickson's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship, Hematology/Oncology, 2006 - 2010
  • New York Presbyterian Hospital
    New York Presbyterian HospitalResidency, Internal Medicine, 2003 - 2006
  • Columbia University College of Physicians & Surgeons
    Columbia University College of Physicians & SurgeonsClass of 2003

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2020 - 2021
  • NY State Medical License
    NY State Medical License 2010 - 2021

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma. 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

  • Aadi Bioscience Breakthrough Therapy Nab-Sirolimus (ABI-009) Independent Reviewed Data Released from the AMPECT Registration Trial in Advanced PEComa
    Aadi Bioscience Breakthrough Therapy Nab-Sirolimus (ABI-009) Independent Reviewed Data Released from the AMPECT Registration Trial in Advanced PEComaNovember 15, 2019 00:45
  • Big, Fat Tumors: Liposarcomas Can Top 70 Pounds
    Big, Fat Tumors: Liposarcomas Can Top 70 PoundsNovember 13, 2018 17:38

Hospital Affiliations